Here, we demonstrate that Bixin is a potent activator of AMPK and that AMPK is required for the activation of the PERK/eIF-2α/ATF4 pathway induced by Bixin or by its combination with TRAIL in CRC cells. The gene discussed is ATF4; the disease is colorectal carcinoma.